Estimation of BDNF gene polymorphism and predisposition to dependence development for selected psychoactive compounds: Genetic aspects of addiction with the selected drugs, amphetamine, tetrahydrocannabinol and opiates

Human and Experimental Toxicology

Volumn 32, Issue 3, 2013, Pages 236-240

  Biskupska, J ^a   Borowiak, K S ^a   Karlin Grazewicz, K ^a   Janus, T ^a   Waloszczyk, P ^a   Potocka Banas B ^a   MacHoy Mokrzynska A ^a   Ossowski, A ^a   Ciechanowicz, A ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

addiction; amphetamine; brain derived neurotrophic factor polymorphism; opiates; THC

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE 2 RECEPTOR; NARCOTIC ANALGESIC AGENT; TETRAHYDROCANNABINOL;

ADDICTION; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; FEMALE; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AMPHETAMINE; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OPIATE ALKALOIDS; POLYMORPHISM, GENETIC; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS; TETRAHYDROCANNABINOL; YOUNG ADULT;

EID: 84875276972     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327112459203     Document Type: Article

References (17)

1. Van den Bree MBM, Johnson EO, Neale MC, Pickens RW. Genetic and environmental influences on drug use and abuse/dependence in male and female twins. Drug Alcohol Depend. 1998 ; 52: 231-241
2. Samochowiec A, Mordasewicz A, Arentowicz G, Samochowiec J. Wplyw badań genetycznych na poznanie patogenezy uzależnień. Psychiatria. 2005 ; 2: 9-18
3. BiskupskaJ. Estimation of DRD2 and BDNF genes polymorphism genome and biochemical urine profile of addicted patients(in Polish). PhD Dissertation, Pomeranian University of Medicine, Szczecin, 2009.
4. Uhl GR, Liu QR, Walther D, Hess J, Naiman D. Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am J Hum Genet. 2001 ; 69: 1290-1300
5. Beuten J, Ma JZ, Payne TJ, Dupont RT, Quezada P, Huang W, et al. Significant association of BDNF haplotypes in European-American male smokers but not European-American female or African-American smokers. Am J Med Genet B Neuropsychiat Genet. 2005 ; 139B: 73-80
6. Hauser J, Leszczyńska-Rodziewicz A. Farmakogenetyka leków przeciw-psychotycz-nych. Psychiatria. 2004 ; 1 (2). 81-89
7. Matsushita S, Kimura M, Miyakawa T, Yoshino A, Murayama M, Masaki T, et al. Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. Alcohol Clin Exp Res. 2004 ; 28: 1609-1612
8. Cheng CY, Hong CJ, Yu WY, Chen TJ, Wu HC, Tsai SJ. Brain-derived neurotrophic factor (val66met) genetic polymorphism is associated with substance abuse in males. Brain Res Mol Brain Res. 2005 ; 140 ((1-2)). 86-90
9. Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D, et al. Genetic vulnerability to drug abuse. The D2 dopamine receptor TaqIB1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry. 1992 ; 49: 723-727
10. Gratacós M, Gonzales JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X. Brain-derived neurotrophic factor val66met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders and schizophrenia. Biol Psychiatry. 2007 ; 61: 911-922
11. Karlin GrażewiczK. Polymorphism of BDNF gene and tobacco smoking(in Polish). PhD Dissertation, Pomeranian University of Medicine, Szczecin, 2008.
12. Itoh K, Hashimoto K, Shimizu E, Sekine Y, Ozaki N, Nada T, et al. Association study between BDNF gen polymorphisms and methamphetamine abusers in Japan. Am J Med Genet Nueropsychiatr Genet. 2005 ; 132B: 70-73
13. Lichtermann D, Franke P, Maier W, Rao ML. Pharmacogenomics and addiction to opiates. Eur J Pharmacol. 2000 ; 355: R1 - R3
14. Kreek MJ, Bart G, Lilly C, Laforge KS, Nielsen DA. Pharmacogenetics of human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev. 2005 ; 57: 1-26
15. Vanyukov MM, Tarter RE, Kirisci L, Kirillova GP, Maher BS, Clark DB. Liability to substance use disorders: 1.Common mechanisms and manifestations. Neurosci Biobehav Rev. 2003 ; 27: 507-515
16. Safranow K, Rzewuski R, Bińczak Kuleta A, Czyżycka E, Skowronek J, Jakubowska K, et al. ADA2 allele of the adenosine deaminase gene may protect against coronary artery disease. Cardiology. 2007 ; 108: 275-281
17. Tomita Mitchell A, Muniappan BP, Herrero Jimenez P, Zarbl H, Thilly W. Single nucleotide polymorphism spectra in newborns and centenarians: identification of genes coding for rise of mortal disease. Gene. 1998 ; 223: 381-391